Accessibility Menu
 

Cibus

(NASDAQ) CBUS

Current Price$2.19
Market Cap$198.59M
Since IPO (2017)-99%
5 Year-99%
1 Year+37%
1 Month-12%

Cibus Financials at a Glance

Market Cap

$198.59M

Revenue (TTM)

$3.64M

Net Income (TTM)

$127.08M

EPS (TTM)

$-2.98

P/E Ratio

-0.96

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Price

$2.19

Volume

84,913

Open

$2.30

Previous Close

$2.19

Daily Range

$1.96 - $2.30

52-Week Range

$1.09 - $4.19

CBUS News

No articles available.

CBUS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cibus

Industry

Biotechnology

Employees

118

CEO

Peter Beetham, PhD

Headquarters

San Diego, CA 92121, US

CBUS Financials

Key Financial Metrics (TTM)

Gross Margin

24%

Operating Margin

-19%

Net Income Margin

-35%

Return on Equity

-223%

Return on Capital

-23%

Return on Assets

-42%

Earnings Yield

-1.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$198.59M

Shares Outstanding

69.20M

Volume

84.91K

Short Interest

0.00%

Avg. Volume

471.73K

Financials (TTM)

Gross Profit

$2.28M

Operating Income

$67.46M

EBITDA

$61.54M

Operating Cash Flow

$50.59M

Capital Expenditure

$578.00K

Free Cash Flow

$51.17M

Cash & ST Invst.

$9.92M

Total Debt

$267.96M

Cibus Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.06M

-12.8%

Gross Profit

$318.00K

-126.2%

Gross Margin

-30.09%

N/A

Market Cap

$198.59M

N/A

Market Cap/Employee

$1.26M

N/A

Employees

157

N/A

Net Income

$31.29M

-35.4%

EBITDA

$8.17M

+151.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$258.04M

-1080.8%

Accounts Receivable

$703.00K

-32.5%

Inventory

$0.00

N/A

Long Term Debt

$264.80M

+742.0%

Short Term Debt

$3.17M

-34.5%

Return on Assets

-41.66%

N/A

Return on Invested Capital

-23.41%

N/A

Free Cash Flow

$13.51M

+3.9%

Operating Cash Flow

$13.42M

+4.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VXRTVaxart, Inc.
$0.66-2.61%
UNCYUnicycive Therapeutics, Inc.
$6.63-0.30%
IMUXImmunic, Inc.
$1.26-4.55%
RPTXRepare Therapeutics Inc.
$2.65+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$171.24-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
EEIQEpicQuest Education Group International
$8.44+2.09%
MARAMara Holdings
$8.58+0.04%

Questions About CBUS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.